Matthew E. Korenberg - President & COO at Ligand Pharmaceuticals Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
President & COO
Stock Symbol
LGND on Nasdaq, LGNDZ, LGNXZ, LGNYZ, LGNZZ on OTC
All Insider Reports
All Insider Reports

Matthew E. Korenberg - trading volume in the past year for Ligand Pharmaceuticals Inc

Holdings reported by Matthew E. Korenberg for Ligand Pharmaceuticals Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 49.5K $5.26M $106.32 Aug 26, 2024 Direct
Employee Stock Option (right to buy) 58.5K Feb 27, 2024 Direct Common Stock

Transactions reported by Matthew E. Korenberg for Ligand Pharmaceuticals Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.